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or most of the twentieth centu-
ry, government agencies charged
by law with managing wildlife were
dedicated to building the size and
productivity of populations of game
species. Under a utilitarian philoso-
phy of wildlife conservation, this ded-
ication made sense and, in its time,
was arguably a highly progressive
view of wildlife (Dunlap 1988).
In the United States, state game
management went far to reverse the
wildlife catastrophe of the nineteenth
century. In the 1800s hunting and
trapping for commercial markets
drove Carolina parakeets and passen-
ger pigeons extinct and nearly extir-
pated bison, elk, deer, beavers, egrets,
waterfowl, songbirds, and any other
furred or feathered creature that could
make a meal or adorn a hat (Tober
1981). Predatory birds and mammals
were shot on sight because of the
threat they posed to domestic live-
stock and poultry and because they
were believed by some to be genuine-
ly evil (Dunlap 1988).1
Through an aggressive program of
reintroduction, habitat management,
and restrictions on killing, state wild-
life agencies succeeded in restoring
populations of deer, elk, beavers,
otters, waterfowl, and other game and
fur-bearing species (Gilbert and Dodds
1992). The linchpin of this effort was
recreational hunting and trapping,
which furnished funding (through
license sales and Pittman-Robertson
grants), volunteer labor, and a dedi-
cated political constituency.
At the beginning of the twenty-first
century, this neat system is unravel-
ing. Demographic changes are pro-
ducing a shrinking and aging popula-
tion of hunters and trappers (hunters,
for example, now represent only 7
percent of the total U.S. population)
(U.S. Fish and Wildlife Service 1997);
a growing public appreciation of
“nongame” species that have been
neglected, and even harmed, by 
management of game species; and
changes in public values, from utili-
tarian views to moral views of wildlife
(Kellert 1985; Dunlap 1988). The
biggest challenge to the system may
arise from the failure of state agen-
cies to respond effectively to the
problems associated with dense popu-
lations of deer, geese, and other
species, especially in urban and sub-
urban communities.
How could a system founded on
hunting and trapping—killing—find
itself unable to control wildlife popu-
lations and solve problems associated
with abundant wildlife? There are sev-
eral reasons. Reflecting cultural atti-
tudes—and regulations—that discour-
age the killing of females, public
hunting has focused on removing
male deer and other big-game ani-
mals, leaving populations streamlined
for reproduction. Many of the most
severe wildlife conflicts arise in loca-
tions that are effectively unhuntable,
such as parks, research campuses, and
suburban neighborhoods. Killing of
some species, such as wild horses, is
simply unacceptable to the public.
The public’s tolerance of invasions of
their parks and backyards by armed
strangers is declining just as its sym-
pathy for wild animals and its interest
in nonlethal solutions to wildlife prob-
lems are rising. 
While the public is searching for
new, humane approaches to solving
conflicts with wildlife, state wildlife
agencies persist in recommending
hunting and its variations. Wildlife
agencies in some states, such as New
York, are required by law to promote
recreational hunting (Marion 1987).
But, more pervasively, most state
agency personnel have strong cultur-
al and political links to the hunting
and trapping community. This com-
munity is (somewhat irrationally) hos-
tile to the concept of nonlethal man-
agement of wildlife (Kirkpatrick and
Turner 1995; Hagood 1997). Wildlife
agencies’ advocacy of hunting and
trapping is coupled with a reluctance
to pursue or encourage research into
other approaches. As a result, the pub-
lic is turning elsewhere for solutions.
There are, effectively, only two
choices for actively managing the size
of animal populations: reducing the
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rate. (Local population size may also
be controlled by movement of individ-
uals in and out; but when the size 
of animal populations concerns us,
movement of individuals merely relo-
cates the concerns. We are not
absolved of our responsibility for ani-
mals simply because they go some-
where else.) Killing certainly can
reduce and even destroy wildlife pop-
ulations if enough animals of the
right description are removed from
the population. Until the last decade
of the twentieth century, however, fer-
tility control for wildlife was not seen
as a feasible option.
Everything changed between 1988
and 1989. The successful use of a
remotely deliverable immunocontra-
ceptive on free-ranging wild horses at
Assateague Island National Seashore,
in Maryland, opened a new universe of
possibilities for the humane, non-




The history of wildlife fertility control
and its application to the manage-
ment of free-roaming and captive
wildlife populations is relatively short,
perhaps no more than fifty years.
Until the late 1980s, wildlife contra-
ception was a “boutique” subject
among scientists and wildlife man-
agers. This lack of interest is a bit sur-
prising, because the technology devel-
oped for contraception in humans has
been impressive and its application to
wildlife is fundamentally sound, at
least in a pharmacological context.
Various compounds developed for use
in humans were first tested in animal
models. The resistance to new ap-
proaches in wildlife management,
which played a significant role in the
slow pace of development and interest
in wildlife contraception, stem not
from science but from a variety of so-
cial, cultural, and economic factors.
That said, the history of wildlife
contraception can be traced broadly
by examining the technological ap-
proaches and, more specifically, the
nature of the chemicals, hormones,
and other compounds that have been
applied to various species. Chronolog-
ically, these approaches can be classi-
fied as (1) nonhormonal chemicals,
(2) steroid hormones, (3) non-
steroidal hormones, (4) barrier meth-
ods, and (5) immunocontraceptives.
This oversimplification is com-
pounded by the various permutations
of chemical agent, delivery system,
and specific species. For example, a
contraceptive can be delivered (1)
orally, (2) by surgically placed im-
plant, (3) by hand-injection, or (4) by
remotely delivered dart.2 The histori-
cal development of wildlife contracep-
tives had to take into account whe-
ther the animal was (1) small and
easily live-trapped, (2) usually wary
and unapproachable, (3) living in a
captive setting, (4) capable of being
induced to take baits, or (5) classified
as a food animal by the U.S. Food and
Drug Administration (FDA). 
Nonhormonal
Compounds 
Nonhormonal compounds have been
used most extensively in birds. Some
of the compounds used were classi-
fied as fungicides and seed disinfec-
tants (Arasan®, DuPont Co.) (Elder
1964), others as anticholesterol
agents (22,25-diacholesterol dihy-
drochloride, later marketed as Orni-
trol®, G. D. Searle and Co.) (Wofford
and Elder 1967). In both cases, fertil-
ity was inhibited but toxic effects
made the compounds unacceptable.
Most of the other compounds used
for birds (thiotepta and triethylene
melamine) had similar shortcomings
(Davis 1959, 1962). In general, non-
hormonal compounds were aban-
doned because of their accompanying
toxic effects. While some degree of
contraception, and in a few cases ster-
ilization, could be achieved, the ad-
ministered dose had to be very pre-
cise. This was not possible with oral
delivery in wildlife. In addition, the
mechanisms of action were poorly
understood, and it is unlikely that any
of these compounds could have
passed the rigorous regulatory re-
quirements of today’s FDA or Envi-
ronmental Protection Agency (EPA).
Some nonhormonal compounds
were derived from plant products and
based on historical evidence that
Native Americans used certain plants
for contraceptive purposes. A comp-
rehensive review (Farnsworth and
Waller 1982) listed fifty plant families
with documented antifertility effects
in males and females. Despite some
controlled tests with laboratory ani-
mals (Cranston 1945; Barfnect and
Peng 1968) and a few wild species of
rodents (Berger et al. 1977) and re-
ports of occasional interference with
fertility in humans (Shao 1987), few
investigators have attempted to ex-
ploit these naturally occurring sub-
stances to control reproduction in
wildlife. This area remains a fertile
subject for interested scientists.
Steroid Hormones
Research into the use of steroid hor-
mones for wildlife fertility control be-
came common in the 1960s and ’70s
and was based on the research origi-
nally directed at human fertility con-
trol (Pincus et al. 1958). In general,
steroid hormones work as contracep-
tives by feeding back upon the hypo-
thalamus and/or pituitary glands and
depressing gonadotropic hormones,
thereby reducing or eliminating ovu-
lation or spermatogenesis, or by
changing the speed with which the
ovum moves through the oviducts.
Diethylstilbestrol (DES, a synthetic
estrogen) was introduced into bait
and fed to foxes (Vulpes vulpes) (Lin-
hart and Enders 1964; Cheatum
1967; Oleyar and McGinnes 1974;
Allen 1982), coyotes (Canis latrans)
(Balser 1964; Brushman et al. 1967),
whitetailed deer (Odocoileus virgini-
anus) (Harder 1971; Harder and
Peterle 1974), and black-tailed
prairie dogs (Cynomys ludovicianus)
(Garrott and Franklin 1983) with sig-
nificant contraceptive effects. Anoth-
er steroid, mestranol, which is closely
related to DES, was fed to red foxes
(Storm and Sanderson 1969), small
rodents (voles, rats, and mice) (Marsh
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and Howard 1969; Howard and Marsh
1969; Storm and Sanderson 1970),
and cats (Burke 1977) with some
contraceptive success, but bait accep-
tance decreased quickly. At about the
same time, oral medroxyprogesterone
acetate (MPA) was tested in red foxes
(Storm and Sanderson 1969). Shortly
thereafter, other investigators ex-
plored the use of oral progestins for
controlling fertility in domestic can-
ids. Oral melengestrol acetate (MGA)
was highly effective in inhibiting fer-
tility in dogs (Sokolowski and Van
Ravenswaay 1976) and a related com-
pound, megestrol acetate (MA), was
approved for commercial use in dogs
(Ovaban®, Schering Corporation)
(Wildt and Seager 1977). 
The use of these and similar oral
steroid hormones in wildlife was re-
stricted by problems with bait accep-
tance and dosage and by environmen-
tal concerns, especially effects on
nontarget species (all these steroids
pass through the food chain). These
problems changed the focus of wild-
life contraceptive research to more
narrowly targeted delivery systems.
Steroid hormones were administered
via injection or surgicallyplaced im-
plants in wapiti (Cervus elaphus)
(Greer et al. 1968), large exotic spe-
cies of cats (Seal et al. 1976), deer
(Bell and Peterle 1975; Levenson
1984), and wild horses (Equus cabal-
lus) (Kirkpatrick et al. 1982; Plotka
and Vevea 1990). Significant contra-
ceptive effects were achieved in these
species, but several new problems
arose. Application of these steroids to
free-roaming wildlife required rela-
tively large doses of the compounds,
negating the use of remote delivery
via darts. This meant that each animal
had to be captured before it could be
hand-injected or given a surgical im-
plant. This was impractical with most
species, because of the stresses associ-
ated with capture, the frequency with
which the steroid had to be adminis-
tered, and the large doses that had to
be administered. Unknown at the time
but evident in later years were various
pathologies that resulted from long-
term use of these steroids, particularly
among (but not restricted to) felids
(Buergelt and Kollias 1987). These
molecules were also shown to have
profound effects upon the behavior 
of treated animals, something that
would be undesirable in valued wild-
life species.
Norplant® implants containing lev-
onorgestrol were effective in striped
skunks (Mephitis mephitis) (Bickle et
al. 1991), and raccoons (Procyon lotor)
(Kirkpatrick, unpublished data), which
could be easily captured in live traps in
urban settings, but these two species
were clearly an exception to the practi-
cal application of injectable or implant
steroids to larger species.
Nonsteroidal
Hormones
Wildlife contraceptive research with
nonsteroidal hormones has been large-
ly confined to agonists and antagonists
of gonadotropin releasing hormone
(GnRH) (Becker and Katz 1997). Nor-
mally GnRH signals the pituitary to se-
crete the gonadotropin luteinizing
hormone (LH) or follicle stimulating
hormone (FSH), both necessary for
normal function in the ovaries and
testes. The agonists and antagonists of
GnRH block the effects of GnRH on
the pituitary by one of several mecha-
nisms. These compounds have been
used successfully to inhibit fertility in
dogs (Vickery et al. 1984, 1985; Inaba
et al. 1996), monkeys (Macaca spp.)
(Fraser et al. 1987), and a variety of
other species. To date, however, these
compounds have been short-lived in
their effects and require large doses
for extended effectiveness.
Barrier Methods
Mechanical birth control devices have
been tested in white-tailed deer (un-
successfully), horses (successfully),
and a variety of zoo animals (mixed
results), but the logistics of applica-
tion to free-roaming wildlife are pro-
hibitory in most species. These meth-
ods have included IUD-like barriers
for the deer (Matschke 1980) and
horses (Daels and Hughes 1995) and
silastic vas deferens plugs in the zoo
animals (Porton et al. 1990). More
comprehensive reviews of the history
of wildlife contraception exist (Kirk-
patrick and Turner, 1985, 1991).
Immunocontraception
More recently, immunocontraception,
or vaccine-based fertility control, be-
came a reality for use in wildlife. Im-
munocontraception is based on the
same principles as is disease preven-
tion through vaccination. Humans
and other animals are vaccinated
against diseases by injections of dead
or attenuated disease bacteria or vi-
ruses or of molecules that are harm-
less but similar to toxins the disease
organisms produce. The stimulated
immune systems then produce anti-
bodies against some essential event or
structure in the reproductive process.
A variety of immunocontraceptive
vaccines are under development, in-
cluding vaccines against brain repro-
ductive hormones such as GnRH
(Hassan et al. 1985; Ladd et al. 1988,
1989; Bell et al. 1997) and LH (Al-
Kafawi et al. 1974) and vaccines
against sperm (Primikoff et al. 1988;
Herr et al. 1989) and egg (Florman
and Wassarman 1985), which prevent
fertilization. One of the first immuno-
logical approaches was a vaccine
against the zona pellucida of the
mammalian egg, which was patented
as an antifertility agent in 1976 by R.
B. L. Gwatkin for Merck and Compa-
ny (Skinner et al. 1996). In 1988 this
vaccine was applied to wild horses
with great success. Success with the
porcine zona pellucida vaccine (PZP)
has opened the door to a practical
approach to wildlife fertility control;
since then other experiments with anti-
sperm vaccines have been initiated.
The biology of the PZP vaccine,
which is derived from pig eggs, is
both simple and complex. An extra-
cellular matrix known as the zona pel-
lucida (ZP) surrounds all mammalian
eggs. The ZP consists of three major
glycoprotein families, one of which,
ZP3, is thought to be the principal
sperm receptor in most species (Pra-
sad et al. 2000). When the vaccine is
injected into the muscle of the target
female animal, it stimulates her im-
mune system to produce antibodies
against the vaccine. These antibodies
attach themselves to the sperm re-
ceptors on the ZP of the target’s eggs
and distort their shape, thereby block-







In the late 1980s, the failure to
achieve practical results and the dan-
gers associated with steroid hor-
mones had led to a reexamination of
the problems associated with wildlife
contraception. Research had been
proceeding without an idealized stan-
dard by which to evaluate each new
approach. Kirkpatrick and Turner
(1991) created such a standard,
which included the following goals:
1. Contraceptive effectiveness of at
least 90 percent
2. The capacity for remote delivery
with no (or minimal) handling of ani-
mals
3. Reversibility of contraceptive
effects (more important for some spe-
cies than for others)
4. Safety for use in pregnant animals
5. Absence of significant health
side effects, short or long term
6. No passage of the contraceptive
agent through the food chain
7. Minimal effects upon individual
and social behaviors
8. Low cost
While some of these goals are more
or less arbitrary, they at least provid-
ed reasonable guidelines for discus-
sion and planning. They were built
exclusively around wild-horse contra-
ception and did not address all prob-
lems associated with diverse species
and settings.
In the development of the PZP vac-
cine for certain species, some of these
problems became clear. The chal-
lenge of deer contraception, for ex-
ample, even in urban areas, was and is
to develop a single-dose form of the
vaccine that would provide at least
one, and perhaps several, years of
contraception from one application.
(The use of the raw, native form of the
PZP vaccine requires two inoculations
the first year, which can be very diffi-
cult with wary species like deer.) The
challenge of elephant contraception,
where doses of vaccine must be ten
times larger than standard wild-horse
or deer doses, raised the need for the
development of a synthetic form of
the vaccine. The process of producing
the native PZP vaccine is laborious,
and the number of doses that can be
produced in a year is limited at this
time by the production process. A
synthetic form of the vaccine would
expand the application of wildlife con-
traception beyond present logistical
restrictions and eliminate some of
the regulatory concerns raised by the
use of natural products.
The mere availability of a good phy-
siological immunocontraceptive does
not insure its effective application to
wildlife. The first step in the develop-
ment of a wildlife contraceptive is to
test its efficacy in captive animals or
domestic counterparts, but once this
has been done and physiological effi-
cacy has been determined, strategies
for application to free-roaming spe-
cies must be developed. It is a large
leap from inoculating a deer in a pen
to inoculating a wild free-roaming
deer; it’s yet another leap from ad-
ministering the vaccine in the field to
controlling a wildlife population. 
Actual application to free-roaming
species requires a variety of delivery
and access strategies. Immunocon-
traceptives can currently be delivered
by intramuscular injection: an animal
must be given the vaccine either by
hand injection or by a dart. Two deliv-
ery systems require at least two
access strategies. Hand injection re-
quires physical capture of the target
animal; it increases the stress for the
target animal, danger to the per-
son(s) doing the work, and expense.
Although in some settings, such as
zoos, access is not so great a problem,
it is not always possible to hand-inject
animals without causing some degree
of capture-related stress. In other sit-
uations, such as with wild horses in
the West, hundreds of animals at a
time are rounded up for entry into
adoption programs, and it is relative-
ly easy to hand-inject animals as they
pass through a chute.
For most species of wildlife, the only
delivery option is by dart. It has ad-
vantages and disadvantages. The most
obvious advantage is that it eliminates
the need for stressful capture of ani-
mals. The small volume of vaccine ne-
cessary to immunize an animal (1.0
cc) permits the use of very small and
light darts. This increases the effective
range of darting and decreases the
chances of injury to the target animal.
The disadvantages include the need to
approach the animal to within fifty
meters, the need to separate the ani-
mals that have been inoculated from
those that haven’t, and the labor-in-
tensive nature of the endeavor.
Despite the fact that inoculation of
free-roaming wildlife with a contra-
ceptive vaccine is at best difficult, a
significant degree of success has been
achieved under field conditions.
Wild Horses
Liu et al. (1989) first discovered that
the PZP vaccine would inhibit fertility
in domestic mares. Soon after, wild
horses were treated with the PZP vac-
cine on Assateague Island National
Seashore, in Maryland; studies have
continued for twelve years. The vac-
cine was delivered remotely, with
small darts. Contraceptive efficacy
was greater than 95 percent (Kirk-
patrick et al. 1990). The vaccine was
safe to administer to pregnant ani-
mals and did not interfere either with
pregnancies in progress or the health
of the foals born to inoculated moth-
ers. A single annual booster inocula-
tion was sufficient to maintain the
contraceptive effects (Kirkpatrick et
al. 1991), and contraception was
reversible after three and four years of
treatment (Kirkpatrick et al. 1992,
1995a, 1996a). No changes occurred
in the social organization or behav-
iors of the treated animals. In 1994
the National Park Service began the
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management of the Assateague wild
horses via the PZP vaccine and, after
only three years, the herd reached
zero population growth (Kirkpatrick
1995; Kirkpatrick et al. 1997). This
approach as of 2000 was being ap-
plied to large wild-horse herds in Ne-
vada (Turner et al. 1996a), and trials
with feral donkeys (E. asinus) in Vir-
gin Islands National Park have been
successful (Turner et al. 1996b).
White-Tailed and
Black-Tailed Deer
Populations of white-tailed deer and,
to a lesser extent, black-tailed deer
(O. hemionus) exploded in North
America during the last two to three
decades of the twentieth century. The
causes of the population explosion
are undoubtedly complex. It is gener-
ally attributed to the use of high-yield
crops; the spread of deer-friendly sub-
urbs, which offer a diverse menu of
heavily fertilized ornamental shrubs
and grasses intermingled with dis-
turbed “natural areas” such as small
parks and woodlots; increasingly mild
winters; the absence of natural preda-
tors; and recreational hunting prac-
tices ill-suited to controlling deer
populations in suburbs. 
With burgeoning deer populations
and suburban sprawl has come a rapid
rise in conflicts between deer and
people. These have centered on an
increase in deer-vehicle collisions,
damage to crops and ornamental
plants, undesirable impacts on some
forest ecosystems, and tick-borne
zoonotic diseases, particularly Lyme
disease (Conover 1997; Rutberg
1997). There is now enormous inter-
est in finding new tools that will allow
people and deer to coexist, and much
public attention has focused on im-
munocontraception. In autumn 1997
alone, for example, The Humane Soci-
ety of the United States (HSUS) re-
ceived requests for information on
deer immunocontraception from peo-
ple in more than sixty communities
across the United States.
The 1988–89 field demonstration
on wild horses at Assateague spurred
preliminary testing of PZP on captive
deer. Effects on captive deer resem-
bled those in wild horses; the two-
shot vaccine protocol was highly ef-
fective, the vaccine could be delivered
remotely, its effects were reversible
after at least two years of treatment,
and no health side effects were appar-
ent (Turner et al. 1992, 1996c, 1997;
Kirkpatrick et al. 1997; see also
Miller et al. 1999). A subsequent trial
with semi–free-roaming deer at the
Smithsonian Institution’s Conserva-
tion and Research Center, in Front
Royal, Virginia, provided evidence
that the vaccine could be delivered re-
motely under field conditions; al-
though there was evidence that PZP
treatments extended the mating sea-
son, treated females gained more
weight than untreated females, pre-
sumably because they were spared the
energetic costs of pregnancy and lac-
tation (McShea et al. 1997). A study
begun in 1993 at Fire Island National
Seashore, New York, launched a series
of field studies that explored the ef-
fectiveness and costs of different field
techniques, vaccination schedules,
and vaccine preparations, as well as
investigated effects of PZP on behav-
ior and survival (Kirkpatrick et al.
1997; Thiele 1999; Walter 2000;
Rudolf et al. 2000).  The Fire Island
study was the first to show that bio-
logically significant numbers of fe-
males could be efficiently and effec-
tively treated in the field; approx-
imately 200 females a year were under
treatment by 1996. However, vaccine
effectiveness in this study was lower
than in previous deer studies, espe-
cially in the first year following treat-
ment, probably due to incomplete 
or misdelivered initial vaccinations
(Kirkpatrick et al. 1997; Thiele 1999,
HSUS unpublished data).
The first demonstration that im-
munocontraception reduced an un-
confined deer population was accom-
plished at the National Institute of
Standards and Technology (NIST).
NIST, a 574-acre federal research facil-
ity within the city of Gaithersburg,
Maryland, supported a deer popula-
tion of approximately 180 animals in
1993. By the time PZP treatments
began in autumn 1996, the popula-
tion had risen to approximately 250,
and it peaked at approximately 300 in
autumn 1997 (Thiele 1999). By au-
tumn 1998, however, more than 90
percent of the NIST females were re-
ceiving PZP treatments, and the popu-
lation had declined about 20 percent
below peak levels by spring 2000
(HSUS, unpublished data). Good ac-
cess to deer for treatment, high pop-
ulation mortality (the majority due to
vehicle collisions), and relatively low
reproductive rate all contributed to
success in controlling this population.
Zoo Animals
A third application of the concept of
wildlife immunocontraception is the
control of the production of “surplus”
animals in zoos. Despite often-heard
discussions of the challenges of
breeding endangered species in cap-
tivity, most zoo species breed quite
successfully, and the production—
and disposition—of surplus animals is
perhaps the largest single problem
facing zoos worldwide. Beginning in
1990 the PZP vaccine was applied to
various exotic species in zoos, begin-
ning with Przewalski’s horses (E.
przewalskii) and banteng (Bos jav-
anicus) at the Cologne Zoo (Kirk-
patrick et al. 1995b), and five species
of deer at the Bronx Zoo (now the
Wildlife Conservation Center) (Kirk-
patrick et al. 1996b). The PZP vac-
cine has been tested in more than
ninety species in more than seventy
zoos worldwide (Frisbie and Kirk-
patrick 1998). Today it is reducing
zoo births and providing some relief
to the problem of surplus animals.
African Elephants
A fourth major application is under
way in Africa. Devastated by the lucra-
tive trade in elephant ivory, popula-
tions of African elephants (Loxodonta
africana) were reduced to dangerous-
ly low numbers during the 1970s and
1980s. Elephants basically retreated
to the sanctuary of national parks. In
the meantime, much former elephant
habitat outside of these parks has
come under intensive agricultural
use. In a sense Africa’s elephant popu-
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lations are now trapped in the nation-
al parks. As poaching has diminished,
their numbers are increasing by as
much as 5 percent per year. Ironically
in some areas elephants are now
threatening both the ecosystems of
national parks and their own health.
In recent years this problem has been
managed through “culling,” a eu-
phemism for shooting. Four African
nations currently kill elephants in ord-
er to keep populations within the car-
rying capacity of their parks. (Kruger
National Park, in South Africa, killed
300 to 700 elephants annually for
thirty years but suspended culling in
1995.) This is tragic, particularly for a
species that is believed to understand
the concept of death.
In 1995 preliminary experiments
provided evidence that the PZP vac-
cine would work in elephants. Several
zoo elephants were treated with the
vaccine and, while these were not
breeding animals, we determined
that they produced antibodies against
the vaccine. In October 1996 twenty-
one elephants in Kruger National
Park were captured, radio-collared,
and treated with the PZP vaccine in
order to determine its contraceptive
efficacy. In November 1996 and again
in June 1997, each treated elephant
was given a single booster inoculation
by means of a dart fired by a shooter
in a helicopter. None of the animals
was captured for these booster inocu-
lations, proving that elephants need
not be captured to be vaccinated
(Fayrer-Hosken et al. 1997). In this
trial pregnancy rates in elephants
were reduced from 90 percent in un-
treated control animals to approxi-
mately 37.5 percent in treated ani-
mals. Based on the successful pre-
liminary results, there may be a non-
lethal solution to the wise manage-
ment of park elephants. Additional
studies designed to increase the effi-
cacy of the vaccine in elephants were
carried out in 1998. In this latest
round of trials, fertility was reduced
by 75 percent. There were no changes
in behavior among the treated ani-
mals, the contraceptive effects were
reversible, and the reproductive sys-
tem of the treated animals (uteri and
ovaries) remained normal.
Other Species
In May 1997 ZooMontana, under con-
tract to the U.S. Navy, began treating
thirty water buffalo (Bubalis bubalis)
on the island of Guam with the PZP
vaccine. Preliminary results indicate
that the experiment significantly
reduced pregnancies in these ani-
mals. These results have led to a new,
five-year project by the U.S. Navy and
the U.S. Fish and Wildlife Service
using PZP to control water buffalo on
the U.S. naval base at Guam. This pro-
ject will set the important precedent
of nonlethal control of wildlife by the
Department of Defense.
On Point Reyes National Seashore
in California, Tule elk (C. elaphus
nannodes) are being treated with PZP
as part of a series of tests to deter-
mine whether the herd can be man-
aged with contraception. Preliminary
evidence shows that elk can be suc-
cessfully contracepted with PZP
(Kirkpatrick et al. 1996b; Heilmann




The PZP vaccine appears to come
close to the optimum contraceptive
agent when measured against the
“ideal” wildlife contraceptive. So far,
at least, its physiological actions
appear to be sound and safe; it does
not appear to pass through the food
chain; and it is not associated with
immune responses to somatic tissues
(Turner et al. 1997; Barber and Fayr-
er-Hosken 2000). However, the ideal
wildlife contraceptive vaccine would
require only a single inoculation in
order to achieve several years of con-
traception. It would use adjuvants
that have already been federally
licensed for use in food animals,
instead of the experimental or nonap-
proved adjuvants currently in use, or
use no adjuvants at all. The remote
delivery system would in some man-
ner mark the animal as well as inocu-
late it, so that it could be distin-
guished from untreated animals. The
ZP antigen itself would be readily
available in large and inexpensive
quantities,which suggests the need
for genetically-engineered or synthet-
ic forms. Current research addressing
these goals is described below.
A One-Inoculation
Vaccine
The current vaccine requires animals
to be treated twice before full effec-
tiveness is achieved, with the second
vaccination being administered a few
weeks before the onset of the breed-
ing season. However, it is quite diffi-
cult to treat individual wild animals
twice, and the time just prior to the
breeding season is not always the
most practical time for administering
treatments. Consequently, research is
focusing on the development and
testing of a longer-acting one-inocula-
tion vaccine. 
The first approach to a one-inocula-
tion vaccine used microspheres
formed from a lactide-glycolide poly-
mer that is biodegradable after injec-
tion and nontoxic as it breaks down
(Kreeger 1997; Turner et al. 1997).
These microspheres can be engi-
neered to release the incorporated
vaccine at varying rates by means of
altering the size of the spheres and
the ratio of lactide to glycolide
(Eldridge et al. 1989). In the first
experiment with these microspheres,
in wild horses in Nevada, a single inoc-
ulation achieved the same degree of
contraception as two inoculations of
the raw vaccine. However, the spheres
clogged syringes, needles, and darts,
and delivery was impractical (Turner
et al. 2001). This led to experiments
with small pellets, made of the same
material but shaped to fit into the
needle of a dart. When the pellets are
injected into the muscle of the ani-
mal, along with a bolus of raw vaccine
and adjuvant, they begin to erode,
releasing the vaccine at one and three
months. In an initial study with the
pellets, antibody titers in domestic
mares remained at contraceptive lev-
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els for close to a year, and in a small
pilot study with wild mares, signifi-
cant contraception was achieved (Liu
and Turner, personal communica-
tion). Additional research is being car-
ried out in an attempt to develop pel-
lets that will release at nine months,
thereby permitting two years of con-
traception from a single inoculation.
A second approach involves the
packaging of the PZP vaccine in lipo-
somes, which are formed from phos-
pholipids and cholesterol in saline
(Brown et al. 1997a). This prepara-
tion, which is being tested under the
name SpayVac™ (NuTech, Halifax,
Canada), has shown especially
promising results for gray seals (Hali-
choerus grypus), some of which
remained infertile for at least six
years after a single dose (Brown et al.
1996, 1997b). Published data con-
cerning the effects of SpayVac in
other species are limited at this time,
but there is considerable interest in
further testing, which is under way.
PZP, Adjuvants, and
the Immune System
The PZP vaccine works in most mam-
malian species because the ZP mole-
cule is similar, but not identical,
among many species. The drawback
to this similarity across species is that
PZP is not very good at causing anti-
bodies to be formed. Thus, it must be
given with a general immunostimu-
lant known as an adjuvant. The adju-
vant, when given with a specific vac-
cine, causes the body to make greater
concentrations of antibodies against
the vaccine, which results in better
contraception. The most effective
available adjuvant, and the one em-
ployed in most previous PZP tests, is
known as Freund’s Complete Adju-
vant (FCA). In many species, however,
FCA also causes localized inflamma-
tion and tissue damage and may trig-
ger false-positive tuberculosis tests
after injection (Hanly et al. 1997).
Thus, the FDA and other regulators,
as well as those concerned with ani-
mal welfare, discourage its wide-
spread use. Several new adjuvants are
under study for use with the PZP vac-
cine, and success may lead to more-
relaxed regulation of the vaccine by
the FDA.
Different adjuvants may target dif-
ferent immune pathways, which has
important implications for both the
mechanism and duration of action
(Weeratna et al. 2000). PZP has been
assumed to work through short-term
activation of the humoral immune sys-
tem. However, some adjuvants appear
to activate the cellular immune sys-
tem, which could lead to the destruc-
tion of target tissues, such as the
ovaries. Preliminary experiments sug-
gest that conjugation of PZP to other
immunogenic molecules, such as key-
hole limpet hemocyanin (KLH) or
tetanus toxoid, may also activate the
cellular immune system. 
Activation of the cellular immune
system against the ZP protein could
lead to irreversible sterilants, as well
as more effective contraceptives. The
ability to cause sterilization rather
than temporary contraception may
represent a huge advantage with
some species in some situations,






Currently the PZP vaccine must be
made as a natural product; the actual
glycoprotein antigen is extracted
from the zona pellucida of pig eggs.
Production of the vaccine is very labor
intensive and must rely on an ade-
quate supply of pig ovaries from
slaughterhouses. It is unlikely that
any given small laboratory operation
can produce more than fifteen thou-
sand 65 µg doses per year. That level
of production can probably meet
demands for wild horses, zoo animals,
and deer, but use in elephants (which
currently requires three 600 µg doses)
and companion animals (which num-
ber in the hundreds of thousands or
millions) will far exceed the ability to
produce the native PZP (see also the
discussion of ethics, below). Thus,
there is a significant need to produce
a synthetic form of the vaccine.
A number of investigators have suc-
cessfully cloned the protein backbone
of the ZP molecules of several species
(Harris et al. 1994; Prasad et al.
2000). Thus far, however, they have
been unsuccessful at producing a
recombinant ZP with contraceptive
effects, probably because of difficul-
ties in glycosylating this backbone.
This step is essential in order to
impart adequate antigenicity to the
antigen. Even several large pharma-
ceutical companies have failed in
their attempts to produce a geneti-
cally engineered form of the vaccine.
Work on this project continues in sev-
eral foreign companies and a number
of research groups; among the most
promising approaches is conjugating
short sequences of the ZP antigen to
tetanus toxin or other nonspecific
immune-system booster (Patterson et




The ability to treat free-roaming
wildlife remotely with darts and know
which animals have been treated is
essential in the course of most appli-
cations in wildlife management. To
this end, a dart has been developed by
Pneu-dart® that inoculates the animal
with vaccine and leaves a small paint
or dye mark on the animal at the
same time. While this would not allow
long-term individual recognition, it
would allow darters to discriminate
between treated and untreated ani-
mals, which is all that is needed when
success is measured by impact on the
population. At the present time, this
dart works in a fairly reliable manner
but only at relatively short ranges;
improvements are being pursued. The
various dyes tested thus far have also
fallen short of the mark. Deer in par-
ticular have a tendency to lick the dye
off the injection site. More perma-
nent, nontoxic dyes must be found
that will survive attention by the tar-
get animal and persist over at least a
three-to-four-week period.
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Delivering contraceptives to wildlife
orally, in baits, would be easier and
more cost effective than darting.
However, for safety and ethical rea-
sons, both the public and regulatory
agencies are likely to demand that any
oral contraceptive must be species
specific. This will be extremely diffi-
cult and expensive to accomplish, and
little progress thus far has been
made. A second problem is that the
PZP vaccine (or any ZP vaccine) is
protein in nature and easily destroyed
by the digestive process of most ani-
mals. Needed is a delivery system that
permits the undigested protein of the
antigen to pass into the lymph of the
target animal’s gastrointestinal sys-
tem. Several strategies to accomplish
this are available. One is to insert a
ZP vaccine into a nontransmissible
bacterial or viral vector; this is the
approach used for the oral rabies vac-
cine, which is incorporated into a
Vaccinia (smallpox) vaccine (Bradley
et al. 1997; Linhart et al. 1997; Miller
1997). Another method would be to
incorporate the ZP vaccine into a
microcapsule designed to be ab-
sorbed through the lymphoid tissue
(or other route) in the digestive tract
(Miller 1997). Until the species-speci-
ficity issue is resolved, however, solv-
ing the technical problems of oral
delivery will not move the idea far
toward management application.
Researchers working with the Aus-
tralian government are seeking to en-
gineer the genes for PZP and similar
contraceptive molecules into trans-
missible, nonpathogenic viruses for
use in controlling populations of
introduced wildlife species such as
European rabbits (Oryctolagus cun-
iculus) (Holland et al. 1997; Robinson
et al. 1997). These viruses would be
introduced into the wild populations,
then transmitted from animal to ani-
mal without further human interven-
tion. While the approach is scientifi-
cally feasible, controlling the spread
of the vaccine would be a serious
problem, and such a vaccine would
raise serious safety and environmen-
tal concerns in the United States and
around the world (see the discussion
of ethics below). 
Abortifacients
At least two research groups are seek-
ing to administer compounds that
will cause abortion in recipient ani-
mals. This has already been shown to
be feasible in deer, with prostaglandin
F2 delivered remotely via biobullet
(DeNicola et al. 1997). By its nature,
however, this method will require an-
nual application, and a multi-year
treatment will not be possible. More-
over, the social objections that will
attend this method of wildlife control
make it an unlikely solution to large-
scale management efforts, especially






The invention of an immunosterilant
for companion animals would be an
extraordinary gift to the millions of
dogs and cats worldwide who suffer
and die each year for want of compas-
sionate care and loving homes. In the
United States alone, an estimated 6
to 8 million unwanted dogs and cats
are euthanized in shelters each year,
and countless other stray, feral, and
abandoned animals live and die under
the harshest conditions imaginable.
Elsewhere the situation for cats and
dogs is far, far, worse. There are many
useful and important approaches to
the problems faced by dogs and cats—
most notably, educational outreach by
animal shelters (in those communi-
ties that even have animal shelters).
However, only effective population
control will allow such problems to be
solved through these efforts.
To be truly useful to animal shelters
and others trying to control stray and
feral populations, the ideal immuno-
sterilant would require only one shot,
be free of harmful or unpleasant side
effects, and cause permanent sterility
(although a multi-year, one-shot con-
traceptive vaccine might be some-
what helpful for controlling stray and
feral populations). Ideally, such a
sterilant should also mimic the be-
havioral and health effects of surgical
sterilization, including reduced ag-
gression in males and reduced inci-
dence of ovarian cancer in females.
As noted above, a number of hor-
monal methods have been used suc-
cessfully for contraception of dogs and
cats (see “History of Wildlife Fertility
Control”). Some, including megestrol
acetate (Ovaban®) and Mibolerone
(the synthetic androgen “Cheque”),
are licensed for use as oral contracep-
tives on dogs and/or cats. However,
behavioral and health side effects are
common, and they are of no use to
animal shelters or for control of stray
and feral populations, since effective-
ness ends soon after treatment stops. 
Thus, immunological approaches
may prove more fruitful, and research
efforts in these fields have been accel-
erating. In an attempt to immunize
dogs against their own LH, injections
of human chorionic gonadotropin
(hCG) were administered (Al-Kafawi
et al. 1974). This experiment failed
because canine LH did not crossreact
with anti-hCG antibodies. An immun-
ological approach to fertility control
was also attempted in cats (Chan et
al. 1981). Feline ovaries were homog-
enized and used to raise rabbit anti-
bodies against the protein fractions.
The antibodies, when administered to
pregnant cats, caused some fetal re-
sorption, but the results were dis-
couraging. As in dogs, nonspecificity
of the antibody appeared to be the
cause of failure.
In a different immunological ap-
proach, male dogs were immunized
against their own GnRH (gonadotro-
pin releasing hormone) with GnRH
conjugated to human serum globulin
or tetanus toxoid (Hassan et al. 1985;
Ladd et al. 1994). Plasma testos-
terone, LH, and sperm counts were all
depressed; however, the effect was re-
versed when antibody levels dropped.
A GnRH vaccine would have several
important advantages. First, it should
work on both sexes. Second, it could
convey the same benefits as surgical
sterilization, including loss of libido
and estrus, reduction of aggressive
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behavior, and reduced incidence of re-
productive tract cancers.
Another promising approach to dog
contraception/sterilization is immun-
ization with the PZP vaccine (Mahi-
Brown et al. 1985, 1988). Small and
infrequent doses of the PZP vaccine
appeared to cause cellular-mediated
immune responses in bitches and led
to a longer-term infertility. Long-term
studies were not carried out, but in
the short term this cellular immune
response was associated with histo-
logic alterations of the ovaries. Con-
cerns about potential pathologies
would have to be resolved before this
approach could be considered safe
(Mahi-Brown et al. 1988). Some of
these concerns might be resolved by
use of a more highly purified PZP
preparation than was used in these
studies. As mentioned above, careful
selection of recombinant ZP peptides
should allow a more targeted immune
response and help resolve these con-





Immunocontraception faces a variety
of technical, cultural, regulatory, and
political obstacles before it will be
used as a tool for management of
free-ranging wildlife. The technical is-
sues have already been discussed:
what is needed is a safe, effective,
one-shot, multi-year vaccine that can
be delivered remotely to wildlife un-
der field conditions. In some ways,
however, the technical obstacles are
the least significant.
In our view, the single most formi-
dable barrier to the adoption of im-
munocontraception as a wildlife man-
agement tool is the entrenched
culture of wildlife use. In the United
States, this culture is most evident in
the wildlife management establish-
ment, which includes the state wild-
life management agencies, much of
the U.S. Fish and Wildlife Service, the
hunting community, the arms and
archery manufacturers, the trapping
and fur industries, and the other com-
mercial interests that profit directly
or indirectly from the killing of
wildlife (Gill and Miller 1997; Hagood
1997). In this paradigm wildlife has
no value or significance apart from its
use. This is evident in the jargon of the
culture: deer are the “deer resource”;
beavers and otters are “fur bearers”;
wildlife is divided into “game” and
“nongame” species; ending an ani-
mal’s life is “harvesting.”
In a culture of use, contraception of
“game” animals is illogical: why pre-
vent animal births when you can in-
stead stimulate births and “harvest” a
surplus for human use? A choice to
contracept rather than kill also intro-
duces into wildlife management a new
moral dimension disconcerting to
those who think in terms of exploita-
tion: that each individual animal has a
claim on the world and on us, a claim
to its own life. Recognizing this claim
collapses the jargon of “harvest” and
“resource” and undermines the para-
digm of use that it supports.
The moral challenge that wildlife
immunocontraception poses to the
culture of use is, in our view, the only
possible explanation for the extraordi-
nary antipathy wildlife immunocon-
traception has generated in state
wildlife agencies and the hunting
community. It is certainly not the
threat that the technology itself
poses to hunting; immunocontracep-
tion, at least the dart-delivered kind,
is not and will not be an effective
management tool in the environ-
ments in which most recreational
hunting occurs (Kirkpatrick and
Turner 1995). 
But the antipathy is unmistakable.
Almost every attempt to get a state
permit to conduct an immunocontra-
ception field study on deer has ex-
ploded into a titanic political battle,
with the state agencies often leading
(or goading) the opposition. One pro-
posed study, in Amherst, New York,
was blocked by a lawsuit by Safari
Club International. Another was near-
ly blocked by the personal interven-
tion of several pro-hunting members
of Congress. The publications of the
hunting industry regularly feature
articles on how immunocontracep-
tion can’t work—it is too cumber-
some and/or expensive, it is failing in
this way or that, and of course, it is
inferior to hunting in every way. One
more extreme hunting newsletter fea-
tured a letter that drew parallels
between our research and that of the
Nazis. In community deer meetings,
angry hunters stand up one after an-
other to denounce immunocontracep-
tion as a fraud, as a threat to wildlife
management and a traditional way of
life, as “playing God,” and as an anti-
hunting plot (Kirkpatrick and Turner
1997). A national bowhunting advoca-
cy group recently began issuing action
alerts notifying its members of our
public speaking engagements. 
In the United States the culture of
wildlife use is waning, especially in the
cities and suburbs, where most people
now live (Kellert 1985, 1993). Interest
in and support for wildlife immuno-
contraception on the part of the pub-
lic, the media, and some state legisla-
tures suggests that this obstacle will
be overcome.
In much of the world, however, the
culture of wildlife use remains domi-
nant and is reflected in the multi-bil-
lion-dollar worldwide trade in wildlife
and wildlife parts (Freese 1998).
Among people struggling to support
their families and maintain human life
and dignity, such attitudes are under-
standable, if tragic. But no such
“necessity defense” can be construct-
ed for the profiteers, the entrepre-
neurs from wealthy nations who make
fortunes trading in wild-caught birds,
bear gall bladders, and rhinoceros
horn. Although the international com-
munity frowns on smuggling, the
entire premise of treaties such as the
Convention on International Trade in
Endangered Species of Fauna and
Flora (CITES) is that wildlife use is
good so long as it is “sustainable.”
Wildlife contraception makes little
sense in that context. Why contracept
elephants when you could shoot them,
eat the meat, and sell the hides and
tusks for great profit? The answers to
that question are not simple. They ul-
timately rest on the morality of shoot-
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ing elephants and the long-term eco-
nomic, social, and spiritual advan-
tages of treating these and other wild
creatures with respect and compas-
sion. But the question will have to be
answered, and answered convincingly,
before immunocontraception can be
widely applied to elephants and other




Several specific regulatory and practi-
cal issues will have to be addressed
and resolved before PZP or other im-
munocontraceptives become main-
stream management tools.
Within the United States, the most
important regulatory barrier is ap-
proval by the Center for Veterinary
Medicine of the U.S. Food and Drug
Administration (FDA). The FDA has
little experience with animal vac-
cines. Most animal vaccines are regu-
lated by the U.S. Department of Agri-
culture (USDA), but the USDA’s
authorizing legislation only permits it
to regulate vaccines for disease pre-
vention. Since pregnancy is not con-
sidered a disease, regulatory authori-
ty reverts to the FDA. Unfortunately,
most of the FDA regulations and stan-
dards that apply to immunocontra-
ception are tailored to approval of
drugs, which are generally more strin-
gently regulated and require more ri-
gorous testing than do vaccines. 
As of mid-2000, research on PZP is
being carried out under the authority
of Investigational New Animal Drug
(INAD) files established with the FDA.
(In our case, the INAD is held by The
HSUS.) The INAD file is the heart of a
process designed to control develop-
ment and testing of new animal drugs
and vaccines and guide acceptable
products toward eventual FDA ap-
proval for marketing and commercial
distribution. Fundamentally, the FDA
asks this question when considering a
product for approval: Is the specific
product safe and effective for its
intended purpose if used as directed?
The question is asked comprehensive-
ly; it extends to manufacturing, stor-
age, packaging, means and schedule
of delivery, animals targeted, and
labeling of the vaccine or drug. These
will be high hurdles for PZP or any
contraceptive vaccine (especially a
recombinant form) or drug to over-
come. But it can be done, and even-
tually it will be done for a safe, ef-
fective wildlife contraceptive.
Since management of wildlife in
the United States is carried out under
state authority (with some exceptions
on federal land), applying immuno-
contraceptives to free-ranging wildlife
will generally require permits from
state wildlife agencies (Messmer et al.
1997). Many will yield such permits
only slowly and grudgingly. However,
as the novelty of the technique wears
off, as its limitations and successes
are demonstrated in field studies, as a
safety record is accumulated, and as
FDA concerns are met, state agencies
will become more comfortable with
immunocontraception techniques.
Some progress has already been
made, at least in the agencies’ rhe-
toric. While in the early 1990s the
response of state agencies to deer
contraception was “no, not now, not
ever,” by the close of the decade many
state agency personnel were conced-
ing that PZP does at least stop deer
from breeding, and they began to
speak of contraception as an impor-
tant tool for future management ef-
forts. Given the scope and serious-
ness of public concerns over deer and
other wildlife, it is inconceivable that
state agencies could resist indefinite-
ly public demands for a humane, non-
lethal tool that could help solve at
least some conflicts with deer.
The practical issues include deter-
mining who will pay for wildlife con-
traception and who will carry it out.
State agencies are uniquely unsuited
to pay for or conduct wildlife man-
agement through immunocontracep-
tion. They have neither the money
nor the personnel (a situation that
certainly aggravates agency worries
over the potential spread of immun-
ocontraception as a management
tool). The resources they do have are
generated principally by hunters, who
repeatedly and loudly voice their ob-
jections to having their license fees
spent on contraception. State legisla-
tures have become accustomed to
state wildlife agencies generating
their own funds and depending on
hunters to conduct management
activities. They are extremely reluc-
tant to start diverting general rev-
enues to these otherwise self-support-
ing agencies. Although some im-
munocontraception studies have re-
ceived state funding and support (no-
tably in New York and Connecticut),
the prospects for state wildlife agen-
cies getting any money to conduct
immunocontraception management
programs in the field are very limited.
If state agencies do not fund and
conduct these programs, who will?
We believe the answers are already be-
ginning to emerge. Generally, HSUS
immunocontraception studies have
been funded at least in part by land
owners, land management agencies,
and communities in which the studies
occur. The wild-horse contraception
projects at Assateague Island and
Cape Lookout National Seashores are
being funded and carried out by the
National Park Service, which is also
involved in supporting and carrying
out the deer project at Fire Island Na-
tional Seashore and the Tule elk pro-
ject at Point Reyes National Seashore.
Wild-horse contraception studies on
western public lands have been coop-
erative efforts of The HSUS, the re-
search team, and the Bureau of Land
Management; over time, the BLM is
increasing its responsibility for carry-
ing out these programs. NIST, part of
the U.S. Department of Commerce, is
jointly undertaking a deer contracep-
tion study with The HSUS on the
NIST campus in Maryland. The U.S.
Navy is implementing fertility control
of water buffalo on Guam. Local agen-
cies, such as Columbus-Franklin Coun-
ty Metro Parks, in Ohio, and Morris
County Parks, in New Jersey, have also
taken lead roles in conducting deer
immunocontraception studies on
their own properties. At Fire Island
and in Groton, Connecticut, funding
has been provided by local communi-
ties and residents. 
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Deer management, in particular, is
increasingly being carried out at the
local level. Confronted with increas-
ing numbers of deer-human conflicts,
town councils, county governments,
park commissions, and other munici-
pal bodies have developed deer-man-
agement plans and employed city
police, animal control officers, volun-
teer hunters, and private contractors
to carry them out. This localization
has been formally recognized in Mary-
land, where the state deer-manage-
ment plan emphasizes local needs
and preferences, and in New Jersey,
where recently approved legislation
establishes community-based deer
management plans. These plans
would be developed locally by county
and municipal governments, submit-
ted to the state divisions of fish,
game, and wildlife for review and ap-
proval, and carried out by either gov-
ernment personnel or private con-
tractors. While the emphasis of these
plans clearly now rests on killing, fer-
tility control is explicitly recognized
in the New Jersey legislation as a local
management alternative.
We envision that immunocontra-
ception projects (indeed, all urban
wildlife management) eventually will
be funded locally, carried out by local
government personnel or private
contractors, and regulated by the
states, which will establish policies,
issue permits, oversee research, and





Ethical questions concerning the ap-
plication of immunocontraception to
wildlife have been raised by people
expressing a wide spectrum of view-
points, from sport hunters to hard-
line animal rights advocates. We
choose to take a pragmatic approach.
When immunocontraception is con-
sidered, it will be considered as one of
several management alternatives, and
so to each of the questions posed be-
low must be added the implicit ques-
tion, “compared to what?” (Oojges
1997; Singer 1997).
Is it right to manipulate a wild ani-
mal’s reproductive system, and poten-
tially its behavior, for human purpos-
es? All other things being equal, our
ethical and esthetic preference would
be simply to leave wildlife alone. We
recognize the intrinsic right of all
wild creatures to live out their lives
unmanipulated by humans, and we
personally take great pleasure in ob-
serving and participating in the con-
tinuing and ever-surprising story of
life on earth. But the lives of many
wild creatures—especially those close
to human habitation—are already
subject to human manipulation,
much of it deliberately or incidentally
destructive. We shape the terms of
animal existence by our settlement
patterns; engineering of land and
water; discharging of the byproducts
of human life into the rivers, oceans,
and atmosphere; and invasion of al-
most every corner of the planet.
And as a practical matter, leaving
them alone is not always a choice we
have. The public demands that action
be taken when public health, safety, or
subsistence are threatened by wildlife.
Not only is this view ethically defen-
sible, but (more to the point) it is also
widespread, and we do not see this
consensus changing in our lifetimes.
The action taken need not be manipu-
lation of wildlife populations; but at
very high population densities, “pas-
sive” management techniques (e.g.,
exclusion and traffic manipulation)
may be insufficient to resolve public
concerns. Alternatives typically con-
sidered include some form of public
hunting, sharpshooting, capture and
relocation or slaughter, or other
actions that are lethal, cruel, or both.
In comparison to those alternatives,
immunocontraception appears to be a
fairly gentle population manipulation.
Isn’t immunocontraception unnat-
ural? Many sport hunters feel that
they fill the ecological niche vacated
by the natural predators that have
been eliminated from the landscape
and that hunting is therefore a natur-
al activity. (Some take this further,
asserting that humans are hunters by
nature and that hunting fulfills some
biological imperative.) To this role
they contrast immunocontraception,
which they dub “unnatural” and
“playing God.” 
A strong case can be made that
sport hunting is not natural. The use
of all-terrain vehicles, laser sights,
GPS units, and other twenty-first-cen-
tury gadgets and gizmos is not natur-
al, nor are the pervasive population,
behavioral, even genetic effects of
American sport hunting: the focus on
trophy animals, the likely disruption
of normal social organization, the dis-
tortion of normal population age and
sex structures. Sport hunter (or
predator) populations are not regu-
lated by game (or prey) populations,
as they would be in nature. Although
the population, behavioral, and genet-
ic effects of immunocontraception are
not yet fully known, they are unlikely
ever to achieve the profound and
unnatural impacts of sport hunting.
Is it right to kill pigs (to make PZP)
to save deer and horses? No. PZP is
produced from the ovaries of pigs pur-
chased from slaughterhouses. If we
believed that more pigs were dying
because we were making PZP, we
would stop. More than 100 million
pigs are killed in slaughterhouses
each year, and we cannot believe that
PZP research has any impact on that
total. Nevertheless, this consideration
adds urgency to the search for a syn-
thetic form of the vaccine, especially
if a form of ZP should ever prove ap-
plicable to companion animals. In
that case, the commercial production
of millions of doses per year might
actually affect the market for dead
pigs, and extraction of PZP from pigs
on that scale would be ethically unac-
ceptable to us.
Would it ever be appropriate to use
oral contraceptives or transmissible
contraceptives on free-ranging wild-
life? Oral contraceptives for wildlife,
packaged in attractive baits, would
certainly make vaccine delivery easier
and cheaper. Consequently, they
would broaden the range of potential
applications. This could be good or
bad. We would consider it desirable if
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contraceptives could replace noxious
lethal controls with minimal behav-
ioral and ecological effects. Like poi-
son baits and pesticides, however, oral
contraceptives offer many opportuni-
ties for abuse. Rather than the careful
and limited application that dart de-
livery forces on our current use of
immunocontraceptives, oral contra-
ceptives could be scattered incau-
tiously and indiscriminately, leading
to unpredictable biological effects on
a large scale. These risks are amplified
if the immunocontraceptives are not
species specific.
The subject of transmissible contra-
ceptives is even more complex. In his
1985 novel Galapagos, Kurt Vonnegut
describes a world in which the human
population is driven nearly to extinc-
tion by a virus that sweeps across the
planet rendering its human hosts
infertile (except for a small group iso-
lated on the Galapagos Islands, where
the plot then unfolds). This is the
deepest fear engendered by the con-
cept of transmissible contraceptives—
that once released, such an agent
could not be controlled and its unan-
ticipated effects  could be catastroph-
ic for the target species, for nontarget
species, and even for our own species.
We believe that there would be abso-
lutely no support in the United States
for release of such an agent: no
wildlife overabundance problem with
which we are presently coping could
justify even considering assuming that
level of risk.
In Australia, where much of the
research on transmissible immuno-
contraceptives is being conducted, a
different story line is unfolding. The
introduction and phenomenal pros-
perity of European rabbits, red foxes,
domestic cats, and house mice has
devastated dozens of native marsupial
species in a true ecological catastro-
phe. Australia’s response has been to
kill these once-welcomed invaders by
the millions with poison, traps, guns,
blasting, gas, disease, and every other
cruel, destructive device imaginable.
That animal welfare catastrophe, in
conjunction with the ecological cata-
strophe, has led animal protection
groups in Australia to support (with
conditions) the ongoing research into
transmissible immunocontraceptives
(Oojges 1997). But because the risks
of releasing such agents would extend
beyond Australia, a clash between Aus-
tralians and the rest of the world
might be anticipated, even among ani-
mal protectionists.
Conclusion
In spite of the frustrations and obsta-
cles—personal, political, and bureau-
cratic—we remain optimistic about
the future of wildlife contraception. It
may be that we are simply optimistic
people, but our optimism draws sup-
port from our experience. One of us
(JFK) has been working on wildlife
fertility control for almost thirty years
and the other (ATR), for just under a
decade; we have seen progress. Oper-
ationally, we’ve progressed in thirty
years from capture, field surgery, and
implantation with gobs of physiologi-
cally and environmentally suspect
steroids to darting animals in the
field at a distance of twenty-five to
fifty yards with one-fifth of a teaspoon
of biodegradable vaccine. In the pub-
lic’s eyes, wildlife contraception has
gone from a joke to a pretty darned
good idea, “if you can make it work.”
Even in the deer meetings we’ve sur-
vived (Kirkpatrick and Turner 1997;
Rutberg 1997), after all the shouting,
blustering, posturing, and accusing is
over, there’s usually someone who
takes us aside and says, “You know,
these animals really are a problem,
but it’s not right to kill them, so if
you could find another way to control
them it would make people really,
really, happy.”
For the animals—the old mares on
Assateague, the old does on Fire Is-
land, and the rest—and for those peo-
ple in the back of the room, we should
all be working to find that other way.
Notes
1These attitudes still linger, and many of these
species, such as gray wolves and grizzly bears, still
confront them in their path to recovery.
2Dart delivery systems have changed dramati-
cally in the past twenty-five years and have
improved significantly the ability to treat free-
roaming animals at greater ranges; thus, dart-
delivered drugs were not an early priority for sci-
entists looking into this field.
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